Diversicare Healthcare Services Inc
Diversicare Healthcare Services — FY2017 Earnings Presentation
34 slides from Diversicare Healthcare Services's earnings presentation, Mar 1, 2018

Slide 1: Investor Update As of December 31, 2017
Nasdaq: DVCR Investor Update As of December 31, 2017

Slide 2: Forward-Looking Statements
Nasdaq: DVCR Forward-looking statements made in this presentation involve a number of risks and uncertainties, but not limited to: as well as other risk factors detailed in the Company's Securities and Exchange Commission filings. The Company has provided additional information in its Annual Report

Slide 3: Non-GAAP Information
Nasdaq: DVCR Non-GAAP Information This presentation contains certain non-GAAP financial measures, including, EBITDA, Adjusted EBITDA and Adjusted EBITDAR. EBITDA is a non-GAAP financial measure which consists of net (loss) income before interest, income taxes, and depreciation and amortization. Adju

Slide 4: Investment Highlights
Nasdaq: DVCR Leading Skilled Nursing Provider Compelling Demographic Trends Management’s Strategic Vision Yielding Results Improving Patient Quality Measures, Census And Skilled Mix Demonstrated Ability To Grow And Enhance Portfolio Positively Trending Financial Results Investment Highlights 4

Slide 5: Executive Leadership
Nasdaq: DVCR • Joined Diversicare in 2012 • 20+ years of experience in the LTC industry • Previous senior leadership positions at: ‒ Golden Living • Licensed Physical Therapist • Licensed Nursing Home Administrator Executive Leadership • Joined Diversicare in 2012 • 10+ Years of senior finance posit

Slide 6: Diversicare at a Glance
Nasdaq: DVCR NE CO OK LA FL (1) IA IL KS (6) OH (5)IN (1) MO (3) AR KY (13) TN (5) PA MS (9) AL (20) SC NC GA VA WV TX (13) 6 Diversicare at a Glance FY16 Revenue $426M – FY17 Revenue $575M; 34.9% Growth Currently – 76 SNFs, 1 ALF – 8,456 Licensed Skilled Nursing Beds – 10 States Headquartered in Br

Slide 7: Company Profile
Nasdaq: DVCR 7 Company Profile Public Company since 1994 NASDAQ Listed Company Symbol: DVCR Added to Russell Microcap Index in 2014 52 week range $8.40 – $12.25 Historically paid $0.22 annual dividend Headquartered in Brentwood, TN

Slide 8: Long Term Care Industry Overview
Nasdaq: DVCR 8 Long Term Care Industry Overview • Compelling Demographic Trends • High Quality Clinical Outcomes • Relative Low Cost of Care • Risks to the Industry and the Company

Slide 9: Compelling Industry Demographics
Nasdaq: DVCR 9 Compelling Industry Demographics Risi n g Deman d St able Su p pl y Sources: AHCA, CMS OSCAR Data and US Census Bureau, US Administration on Aging 15,000 15,500 16,000 16,500 17,000 2000 2002 2004 2006 2008 2010 2012 2014 2016 Number of Skilled Nursing Facilities 0 20 40 60 80 100 199

Slide 10: Compelling Industry Demographics
Nasdaq: DVCR 10 • Long term care spending continues to increase ‒ Medicare and Medicaid expenditures for SNFs expected to grow 65% from 2015 to 2025 ‒ Annual spending on older adults is expected to increase 250% by 2040 Sources: Medpac and US HHS Department Compelling Industry Demographics 20.0 30.0

Slide 11: Relative Cost Per Case of Treatment Across Post-Acute Care Providers
Nasdaq: DVCR 11 Relative Cost Per Case of Treatment Across Post-Acute Care Providers Sources: Medpac and US HHS Department $0 $20 $40 $60 $80 $100 $120 Stroke Hip Fracture Joint Replacement Respiratory w/ Vent Tracheotomy w/ Vent $9 $9 $11 $6 $10 $34 $34 $18 $17 $26 $31 $31 $45 $67 $115 SNF IRF LTAC

Slide 12: Risks to the Industry and the Company
Nasdaq: DVCR Risks to the Industry and the Company A number of risks may impact the Industry in general and the Company in particular, including litigation risks and Government reimbursement/regulation risks. Litigation Risks include: • The provision of health care services results in numerous profe

Slide 13: Risks to the Industry and the Company
Nasdaq: DVCR Risks to the Industry and the Company Government Reimbursement Risks include: • In recent years, there have been initiatives on the federal and state levels for comprehensive reforms affecting the availability, payment and reimbursement of healthcare services in the United States. The I

Slide 14: Company Overview
Nasdaq: DVCR 14 Company Overview • Mature Company • Provides a full spectrum of post-acute healthcare services • Robust operating platform capable of significant growth expansion

Slide 15: Key Strategic Accomplishments
Nasdaq: DVCR Investments made in internal improvements and scalability position Diversicare for external growth Launched Q3 2010 Today Expanded Focus Now On Portfolio Growth Retooling: Areas of Focus Platform Development Operational Improvement Facility Renovations Key Strategic Accomplishments 15

Slide 16: Platform Development and Operational Improvements
Nasdaq: DVCR Implement an Electronic Medical Record (EMR) Solution Centralization of Key Processes People – Processes – Resources Completed – Company repositioned for rapid growth Platform Development and Operational Improvements 16

Slide 17: Key Results and Outcomes
Nasdaq: DVCR 17 Key Results and Outcomes • Improved Quality Measures • Improved patient mix and reimbursement rates • Improved operating and G&A leverage • Demonstrated growth through acquisitions

Slide 18: Results for All Centers: Star Quality Measures
Nasdaq: DVCR Results for All Centers: 5 Star Quality Measures Relative to For-Profit Peer Group 18 3.95 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 4.0 Overall QM Rating DVCR Industry For-Profit Not-For-Profit Diversicare is an industry leader in 5 Star Quality Measures outcomes.

Slide 19: Results: Rate Increases Driven By Higher Acuity
Nasdaq: DVCR A – Resulting from a 2% decrease in rates as a result of sequestration beginning April 1, 2013. Results: Rate Increases Driven By Higher Acuity • Medicare rate growth driven by acuity • 17.7% Increase from FY10 Q3 to FY17 Q4 • 4.2% CAGR 19 $380 $430 $480 Q3 '10 Q4 '10 Q1 '11 Q2 '11 Q3 '

Slide 20: Results: Rate Increases Driven By Higher Acuity
Nasdaq: DVCR • Medicaid rates driven by acuity • 20.1% Increase from FY10 Q3 to FY17 Q4 • 4.7% CAGR Results: Rate Increases Driven By Higher Acuity 20 $145 $150 $155 $160 $165 $170 $175 $180 Q3 '10 Q4 '10 Q1 '11 Q2 '11 Q3 '11 Q4 '11 Q1 '12 Q2 '12 Q3 '12 Q4 '12 Q1 '13 Q2 '13 Q3 '13 Q4 '13 Q1 '14 Q2 '

Slide 21: Results: Growth in Operated Facilities
Nasdaq: DVCR Results: Growth in Operated Facilities • Our ability to integrate facilities onto our platform is proven by our growth and early accretion of new facilities. • We acquired 22 facilities in the fourth quarter of 2016. • On July 1, 2017, we acquired a facility located in Selma, Alabama. 2

Slide 22: Results: Impact Of New Centers
Nasdaq: DVCR Acquisitions are Accretive to earnings within a quarter of acquisitions date – the exceptions being development opportunities like new construction, major renovations, etc. Demonstrated Platform Scalability by successful integration of new facilities New Facility Integration, including

Slide 23: Results: Revenue Impact of Acquisitions
Nasdaq: DVCR Results: Revenue Impact of Acquisitions 23 * For the purposes of this chart, the “same-store group” represents all centers operated by the Company prior to January 1, 2015. $- $20 $40 $60 $80 $100 $120 $140 $160 Q1 ’14 Q2 '14 Q3 '14 Q4 '14 Q1 '15 Q2 '15 Q3 '15 Q4 '15 Q1 '16 Q2 '16 Q3 '1

Slide 24: Results: New Centers and Same-Store
Nasdaq: DVCR *Same-Store group represents all nursing centers acquired by the Company prior to January 1, 2016. Results: New Centers and Same-Store 24

Slide 25: Results: Revenue Growth and Operating Leverage
Nasdaq: DVCR Results: Revenue Growth and Operating Leverage • Continued Company-wide cost reduction efforts in place o Diligent vendor management and product selection criteria o Centralized purchasing functions drive consistency through all facilities o Revenue and operating expenses increased in t

Slide 26: Results: G&A Leverage
Nasdaq: DVCR • Continued G&A reduction efforts in place o Right-sized overhead structure for new portfolio o Centralized core functions to leverage skilled teams • Savings from G&A reductions funded strategic investments Results: G&A Leverage 26 A –G&A expenses increased in the third quarter of 2016

Slide 27: Current Areas of Focus
Nasdaq: DVCR 27 Current Areas of Focus • Continuous quality improvement • Enhancing existing portfolio • Growth through accretive acquisitions

Slide 28: Continue to Enhance Existing Portfolio
Nasdaq: DVCR Continuous improvement of Quality Measures Continue to drive volume of patients served Improve skilled mix / provide high-acuity services Ongoing renovations of existing facilities Continue to Enhance Existing Portfolio 28

Slide 29: Portfolio Growth
Nasdaq: DVCR Achieved goal of doubling the size of the Company in 3 years Target: 5-10 new facilities per year Active acquisition pipeline Expanded operating infrastructure = Scalability Structure flexibility = Several sources of financial capacity Portfolio Growth 29

Slide 30: Acquisition Types
Nasdaq: DVCR • Full Ownership Of Assets • Participate In Value Appreciation • Enhance Facility Ownership Fee-Simple Acquisitions • Minimal Capital Required • Leverage Turnaround Capabilities • Leverage Strong REIT Relationships Assumption of Long-Term Operating Leases 2010 Today 20% 24% 80% 76% Flex

Slide 31: Summary
Nasdaq: DVCR 31 Summary • Improved operational and financial results • Attractive investment dynamics • Repositioned for the future

Slide 32: Key Financial and Operating Statistics
Nasdaq: DVCR Key Financial and Operating Statistics 32 Q4 2017 Q3 2017 Q2 2017 Q1 2017 Q4 2016 Average Daily Census 6,740 6,854 6,749 6,770 6,402 Total Average Daily Census – Medicare & Managed Care 988 994 1,053 1,065 938 Skilled Mix % 14.7% 14.5% 15.6% 15.7% 14.6% Occupancy (Available Beds) 83.3%

Slide 33: Investment Highlights
Nasdaq: DVCR Leading Skilled Nursing Provider Compelling Demographic Trends Management’s Strategic Vision Yielding Results Improving Patient Quality Measures, Census And Skilled Mix Demonstrated Ability To Grow And Enhance Portfolio Positively Trending Financial Results Investment Highlights 33

Slide 34: Appendix A: Reconciliation of Net Income to Adjusted EBITDA and Adjusted EBITDAR
Nasdaq: DVCR Appendix A: Reconciliation of Net Income to Adjusted EBITDA and Adjusted EBITDAR 34 (a) Represents non-recurring costs associated with acquisition-related transactions. (b) Represents non-recurring lease termination receipts, net of expenses, related to the termination of the Carthage,
Source: SEC EDGAR · 8-K filed Mar 1, 2018
More decks from Diversicare Healthcare Services Inc
Q2 2021 Earnings Presentation31 slides · Aug 10, 2021
Q1 2021 Earnings Presentation31 slides · May 11, 2021
Q4 2020 Earnings Presentation31 slides · Mar 11, 2021
Q3 2019 Earnings Presentation5 slides · Oct 31, 2019
Q2 2018 Earnings Presentation35 slides · Aug 2, 2018
Q1 2018 Earnings Presentation35 slides · May 3, 2018